Methods of using E2F2 for the treatment of hypertension

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9187540
APP PUB NO 20100130414A1
SERIAL NO

12447114

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention features compositions and methods of treating or preventing hypertension or a cardiac indication. In particular embodiments, the invention provides E2F2 as a new therapeutic target for the treatment of hypertension or a cardiac indication, and methods of increasing the expression and/or activity of E2F2.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
STEWARD RESEARCH AND SPECIALTY PROJECTS CORPORATION500 BOYLSTON STREET BOSTON MA 02116

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Losordo, Douglas W Chicago, US 18 109
Qin, Gangjian Chicago, US 2 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 17, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00